Company intelligence / Profile preview

Vitreoretinal Consultants

Elmhurst, New York, USA

Ownership: Private
Employees: ~84
Development stage: Other

Overview

Vitreoretinal Consultants of NY is a leading retina specialty practice in New York, providing advanced diagnostics, treatments, and clinical trial access for a broad array of retinal and macular diseases. The group is known for its expertise in managing complex retinal conditions and for its participation in early, influential clinical trials that helped establish current standards of care, including for drugs such as ranibizumab, bevacizumab, and aflibercept[1][11].

Therapeutic areas: Ophthalmology
Modalities: Diagnostic DeviceSurgical DeviceClinical Trial
Industry: Non-Academic Healthcare

Partnerships

Retina Consultants of AmericaNorthwell Health

Beyond the preview

Go deeper on Vitreoretinal Consultants.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitreoretinal Consultants.

Explore the full profile